echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > It's going to take 3.5 billion image agent varieties

    It's going to take 3.5 billion image agent varieties

    • Last Update: 2021-01-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pharmaceutical Network November 25th, recently, the official website of the State Drug Administration shows that Zhengda Tianqing Pharmaceutical Group to imitate the 4 categories of iodized kesha alcohol injection into the administrative approval stage, is expected to be approved in recent days and as reviewed.
    is an X-ray spectral agent, and in 2019, China's public medical institutions will have sales of more than 3.5 billion yuan.
    Iodine kesalol, developed by GE Healthcare AS (General Electric), is the only X-ray diagnostic contrast agent with blood seepage, with high heart safety, strong kidney tolerance, good patient comfort, less interference with cardiopulmonary circulation and other advantages, in the nerve and cardiovascular system, chest, abdomen, pelvic cavity and other organ lesions in the examination to improve the detection rate and diagnosis of the role of identification, by many clinical guidelines and expert consensus at home and abroad.
    meters of intranet data show that in 2019, China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) terminal iodized kesha alcohol injection sales of more than 3.5 billion yuan.
    , Hengrui Pharmaceuticals has a market share of 50.48 per cent and General Electric 34.14 per cent.
    At present, six pharmaceutical companies in the domestic market have been approved to produce iodized kesha alcohol injections, respectively, General Electric, Hengrui Pharmaceuticals, Yangzijiang Pharmaceutical Group, Beiland Pharmaceuticals, Nanjing Zhengtianqing, Staili.
    , so far, iodized kesha alcohol injection evaluation enterprises only Staly.
    Iodine kesal injections to be approved enterprise source: Mi net one-click retrieval of minenet data show that Harbin Triple Pharmaceuticals according to imitation 6 categories of submitted iodized keshaol injection application in the review and approval;
    source: MiNet Database, NMPA
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.